TGGI Trans Global Group Inc (CE)

Cannabis Consortium is working with Counsel to complete the patent application filings, with the goal of having the applications submitted to the USPTO by mid-April.

The mechanical engineer Cannabis Consortium is working with has extensive experience designing and building machinery in the pharmaceutical industry, and has begun designing the filling machine. The machine will fill the device with an Edible substance and CBD oil, and then seal in the fillings to ensure freshness and that the devices being sold have not been tampered with prior to purchase.

Once the applications have been filed Cannabis Consortium release and updated website with 3D renderings of the devices and after the filing machine has been tested a video showing the filing process and the device(s) in use will be posted.

Cannabis Consortium is currently finalizing trademark details for each of the products. Corresponding trademark applications will also be filed with USPTO for each of the products.

About Cannabis Consortium:

Cannabis Consortium is actively pursuing five (5) revenue streams in the cannabis marketplace:

1. Specialty items
2. Foodstuffs/Edibles
3. Beverages
4. Investment
5. Research/New Products

The first three (3) revenue streams are comprised of edible products and ancillary items related to the edible marketplace. The 4th streams Investments into other private cannabis operations. The final stream, research, will focus on the medical benefits of CBD oils for the treatment of animals.

Trans Global Group, Inc. (OTCPINK: TGGI) has an exclusive marketing agreement with Cannabis Consortium for its specialty products.

Bahamas Development Corporation, in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg FD.

Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, release of corporate apps, growth of platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.

Details of the Company's business, finances, appointments and agreements can be found as part of the Company's continuous public disclosure on otcmarkets.com.

For additional information about this release please contact:

Investor Relations:

Matt Dwyer
matt@cannabisconsortium.net
www.cannabisconsortium.net
954-905-9896